DK1156795T3 - Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens - Google Patents

Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens

Info

Publication number
DK1156795T3
DK1156795T3 DK99933301T DK99933301T DK1156795T3 DK 1156795 T3 DK1156795 T3 DK 1156795T3 DK 99933301 T DK99933301 T DK 99933301T DK 99933301 T DK99933301 T DK 99933301T DK 1156795 T3 DK1156795 T3 DK 1156795T3
Authority
DK
Denmark
Prior art keywords
methods
succinic acid
insulin resistance
salts
treating insulin
Prior art date
Application number
DK99933301T
Other languages
Danish (da)
English (en)
Inventor
Igor Anatolievich Pomytkin
Olga Evgenievna Kolesova
Tatiyana Jurievna Ukhanova
Original Assignee
Verteletsky Pavel Vasilievich
Igor Anatolievich Pomytkin
Olga Evgenievna Kolesova
Tatiyana Jurievna Ukhanova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verteletsky Pavel Vasilievich, Igor Anatolievich Pomytkin, Olga Evgenievna Kolesova, Tatiyana Jurievna Ukhanova filed Critical Verteletsky Pavel Vasilievich
Application granted granted Critical
Publication of DK1156795T3 publication Critical patent/DK1156795T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
DK99933301T 1999-03-01 1999-03-01 Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens DK1156795T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/RU1999/000055 WO2000051594A1 (en) 1999-03-01 1999-03-01 Use of succinic acid or salts thereof and method of treating insulin resistance
EP99933301A EP1156795B1 (de) 1999-03-01 1999-03-01 Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz

Publications (1)

Publication Number Publication Date
DK1156795T3 true DK1156795T3 (da) 2004-11-01

Family

ID=20130328

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99933301T DK1156795T3 (da) 1999-03-01 1999-03-01 Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens

Country Status (10)

Country Link
US (1) US6521665B1 (de)
EP (1) EP1156795B1 (de)
AT (1) ATE268170T1 (de)
AU (1) AU4937499A (de)
CA (1) CA2366073A1 (de)
DE (1) DE69917809T2 (de)
DK (1) DK1156795T3 (de)
ES (1) ES2222717T3 (de)
PT (1) PT1156795E (de)
WO (1) WO2000051594A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001076583A1 (en) * 2000-04-10 2001-10-18 Verteletsky, Pavel Vasilievich Synergistic compositions containing choline base and succinic acid for insulin resistance and diabetes
CN101815515A (zh) * 2007-08-02 2010-08-25 布达生物制药有限公司 含有琥珀酸的鼻内用药物组合物
US20120107850A1 (en) * 2009-07-15 2012-05-03 Panasonic Corporation Analysis reagent and analysis device having the analysis reagent carried therein
JP5460183B2 (ja) * 2009-08-28 2014-04-02 パナソニック株式会社 分析用試薬および分析用デバイス
KR20210024056A (ko) * 2018-06-22 2021-03-04 엔진 바이오사이언스 리미티드 혈액 장애 치료를 위한 숙신산 및 유도체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61171417A (ja) * 1985-01-23 1986-08-02 Wakunaga Seiyaku Kk 抗糖尿病剤
JP3581157B2 (ja) 1992-08-19 2004-10-27 株式会社ミツカングループ本社 低耐糖能者用食品

Also Published As

Publication number Publication date
US6521665B1 (en) 2003-02-18
EP1156795B1 (de) 2004-06-02
DE69917809D1 (de) 2004-07-08
ATE268170T1 (de) 2004-06-15
AU4937499A (en) 2000-09-21
WO2000051594A1 (en) 2000-09-08
PT1156795E (pt) 2004-09-30
ES2222717T3 (es) 2005-02-01
DE69917809T2 (de) 2004-11-04
CA2366073A1 (en) 2000-09-08
EP1156795A1 (de) 2001-11-28

Similar Documents

Publication Publication Date Title
DK1539166T3 (da) Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme
DK1202736T3 (da) Nikotin i terapeutisk angiogenese og vasculogenese
EA200401284A1 (ru) Замещённые бензазолы и их применение в качестве ингибиторов киназы raf
CY1107467T1 (el) Χρηση οξεογονων υδρογονοτροφων στελεχων για την προληψη ή την αγωγη πεπτικων διαταραχων
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
CY1105286T1 (el) Ω-καρβοξυαρυλυποκατεστημενες διφαινυλουριες σαν αναστολεις της raf κινασης
DE60035870D1 (de) Kombinationstherapie zur gewichtsreduzierung und fettleibigkeitsbehandlung
DK0950057T3 (da) 3-pyridylenantiomerer og deres anvendelse som analgetika
ATE364595T1 (de) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
DK1228028T3 (da) Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
DK1082131T3 (da) Immunoregulator
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
DK1156795T3 (da) Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens
DK0799618T3 (da) Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO984160L (no) FremgangsmÕte for behandling eller forebyggelse av interstitiell cystitt
DK1073436T3 (da) Forbedret fremgangsmåde til udryddelse af helicobacter pylori
NO20042138L (no) Forbindelser og fremgangsmate for behandling av hyperaktiv blaere
DE60008590D1 (de) Zusammensetzungen von adenosin a1 agonisten und cox2-hemmern
SE9904289D0 (sv) Method and camposition for the treatment of adenovairal ocular infections
DK1227826T3 (da) Sammensætninger omfattende et ekstrakt af Perna canaliculus, methylsulfonylmethan og glucosamid samt anvendelsen heraf
CY1109771T1 (el) Η χρηση της φορμοτερολης στην προφυλακτικη και/ή θεραπευτικη αντιμετωπιση της μυικης απωλειας και/ή του καχεκτικου συνδρομου τα οποια συνδεονται με τις καταβολικες συνθηκες ορισμενων παθησεων. οπως ο καρκινος, to aids, οι μολυνσεις, ο διαβητης και αλλες
BRPI0408984A (pt) método para tratar uma condição de doença mediada por células neutrofìlicas em um paciente, e, uso de um composto de ligação de histamina